Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl Cysteine for Delayed Renal Graft Function
NCT01403506Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetylcysteine in delayed graft function (DGF) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Interleukin-18 at 24 hours and Neutrophil Gelatinase Associated Lipocalin at 24 hours. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT01403506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01403506.